News Post List
The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.
Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress.
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.
Smoking rates falling, aspirin has risks as well as benefits, breast cancer drug U-turn in England and… what's behind the talk of ‘tanning drugs’? Here's our weekly news...